Mitochondrial variations in non-small cell lung cancer (Nsclc) survival

Cancer Informatics

Volumn 14, Issue , 2015, Pages 1-9

  Wang, Zhaoxi ^a   Choi, Sojung ^b   Lee, Jinseon ^b   Huang, Yen Tsung ^d   Chen, Feng ^c   Zhao, Yang ^c   Lin, Xihong ^a   Neuberg, Donna ^a   Kim, Jhingook ^b   Christiani, David C ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Samsung Medical Center   (South Korea)

^c NANJING MEDICAL UNIVERSITY   (China)

^d BROWN UNIVERSITY   (United States)

Author keywords

Haplogroup; Lung cancer survival; Mitochondria genome; Mitochondria mutations; Mitochondrial genome resequencing

Indexed keywords

MITOCHONDRIAL DNA; RNA 16S;

ADULT; AGED; ALLELE; ARTICLE; ATP6 GENE; CANCER SURVIVAL; CO3 GENE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOGROUP; HUMAN; HUMAN TISSUE; INDEL MUTATION; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENE; MITOCHONDRIAL GENOME; MITOCHONDRION; ND4 GENE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RNR2 GENE; SOMATIC MUTATION; SURVIVAL TIME;

EID: 84922014543     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIn.s13976     Document Type: Article

References (37)

1. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407.
2. Maximo V, Lima J, Soares P, Sobrinho-Simoes M. Mitochondria and cancer. Virchows Arch. 2009;454(5):481–95.
3. Enns GM. The contribution of mitochondria to common disorders. Mol Genet Metab. 2003;80(1–2):11–26.
4. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25(34):4647–62.
5. Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene. 2006;25(34):4663–74.
6. Suzuki M, Toyooka S, Miyajima K, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636–41.
7. Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet. 2006;47(1):67–78.
8. Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A. 2005;102(3):719–24.
9. Ohta S. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene. 2006;25(34):4768–76.
10. Shidara Y, Yamagata K, Kanamori T, et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005;65(5):1655–63.
11. ACS, X. Cancer Facts & Figures2007. In: Estimated New Cancer Cases and Deaths by Sex for All Sites U, 2007.
12. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
13. Mountain CF, Lukeman JM, Hammar SP, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol. 1987;35(3):147–56.
14. Ginsberg R, Vokes E, Raben A. Non-small cell lung cancer: diagnosis and staging. In: Devita VJ, Hellman S, Rosenberg S, eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997:868–76.
15. Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287(5460):2017–9.
16. Matsuyama W, Nakagawa M, Wakimoto J, Hirotsu Y, Kawabata M, Osame M. Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum Mutat. 2003;21(4):441–3.
17. Jin X, Zhang J, Gao Y, et al. Relationship between mitochondrial DNA mutations and clinical characteristics in human lung cancer. Mitochondrion. 2007;7(5):347–53.
18. Lévêque M, Marlin S, Jonard L, et al. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. Eur J Hum Genet. 2007;15(11):1145–55.
19. Choi SJ, Kim SH, Kang HY, et al. Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun. 2011;407(1):23–7.
20. Hartmann A, Thieme M, Nanduri LK, et al. Validation of microarray-based resequencing of 93 worldwide mitochondrial genomes. Hum Mutat. 2009;30(1):115–22.
21. Wang Z, Neuburg D, Li C, et al. Global gene expression profiling in whole-blood samples from individuals exposed to met al fumes. Environ Health Perspect. 2005;113(2):233–41.
22. Ingman M, Gyllensten U. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res. 2006;34(Database issue):D749–51.
23. van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009;30(2):E386–94.
24. Ji Y, Zhang AM, Jia X, et al. Mitochondrial DNA haplogroups M7b1’2 and M8a affect clinical expression of Leber hereditary optic neuropathy in Chinese families with the m.11778G→a mutation. Am J Hum Genet. 2008;83(6):760–8.
25. Sun C, Kong QP, Palanichamy MG, et al. The dazzling array of basal branches in the mtDNA macrohaplogroup M from India as inferred from complete genomes. Mol Biol Evol. 2006;23(3):683–90.
26. Tanaka M, Cabrera VM, González AM, et al. Mitochondrial genome variation in eastern Asia and the peopling of Japan. Genome Res. 2004;14(10A):1832–50.
27. Macaulay V, Hill C, Achilli A, et al. Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes. Science. 2005;308(5724):1034–6.
28. Lee HY, Yoo JE, Park MJ, Chung U, Kim CY, Shin KJ. East Asian mtDNA haplogroup determination in Koreans: haplogroup-level coding region SNP analysis and subhaplogroup-level control region sequence analysis. Electrophoresis. 2006;27(22):4408–18.
29. Metspalu M, Kivisild T, Metspalu E, et al. Most of the extant mtDNA boundaries in south and southwest Asia were likely shaped during the initial settlement of Eurasia by anatomically modern humans. BMC Genet. 2004;5:26.
30. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet. 1998;351(9097):185–6.
31. Alexe G, Fuku N, Bilal E, et al. Enrichment of longevity phenotype in mtDNA haplogroups D4b2b, D4a, and D5in the Japanese population. Hum Genet. 2007;121(3–4):347–56.
32. Kokaze A, Ishikawa M, Matsunaga N, et al. Association of the mitochondrial DNA 5178A/C polymorphism with serum lipid levels in the Japanese population. Hum Genet. 2001;109(5):521–5.
33. Tanaka M, Gong J, Zhang J, Yamada Y, Borgeld HJ, Yagi K. Mitochondrial genotype associated with longevity and its inhibitory effect on mutagenesis. Mech Ageing Dev. 2000;116(2–3):65–76.
34. Takagi K, Yamada Y, Gong JS, Sone T, Yokota M, Tanaka M. Association of a 5178C→A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals. Atherosclerosis. 2004;175(2):281–6.
35. Yao YG, Kong QP, Zhang YP. Mitochondrial DNA 5178A polymorphism and longevity. Hum Genet. 2002;111(4–5):462–3.
36. Castri L, Melendez-Obando M, Villegas-Palma R, et al. Mitochondrial polymorphisms are associated both with increased and decreased longevity. Hum Hered. 2009;67(3):147–53.
37. Bilal E, Rabadan R, Alexe G, et al. Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan. PLoS One. 2008;3(6):e2421.